引用次数
引用: 12,404
H-指数: 60
I10-指数 : 171
出版物: 461
Consumption patterns and motivation for use of addictive drugs in schizophrenic patients
Haasen C , Krausz M , Lambert M , Mass R
Psychiatrische Praxis 24 ( 4) 185
13
1997
[Success of new treatments for schizophrenics, as shown by the example of modern antipsychotic drugs].
Krausz M , Lambert M , Moritz S , Naber D
Psychiatrische Praxis
1999
[Admission status of alcohol and drug-dependent patients in "high threshold" access to withdrawal treatment].
Krausz M , Wagner Hb , Lambert M , Schwoon Dr
Psychiatrische Praxis 26 ( 1) 25 -28
1999
Differential diagnosis of psychotic disorders in immigrants
Lambert M , Halilovic H , Haasen C
Psychiatrische Praxis 25 ( 4) 198 -199
4
1998
Clinical high risk for psychosis: gender differences in symptoms and social functioning
Bechdolf A Rietschel L , Lambert M , Karow A , Zink M
Early Interv Psychiatry
86
2015
Diagnostic aspects of psychiatric disorders among migrants
O. Yagdiran , C. Haasen , M. Lambert
Curare 19 ( 2) 347 -352
2
1996
CHANCEN NEUER THERAPIEN SCHIZOPHRENER PATIENTEN AM BEISPIEL MODERNER ANTIPSYCHOTIKA
M. Krausz , M. Lambert , S. Moritz , D. Naber
Psychiatrische Praxis 26
1
1999
The effect of symptoms on functioning and daily life
P Mcguire , Silvana Galderisi , M. Lambert , A Schreiner
European Neuropsychopharmacology 23 ( 2)
2013
Therapieresistenz bei schizophrenen Patienten - Aktueller stand
C. Haasen , M. Lambert , S. Moritz , D. Naber
Psychopharmakotherapie 8 ( 1) 2 -17
1
2001
Quetiapin: ein neues atypisches antipsychotikum in der behandlung schizophrener patienten
M. Krausz , S. Moritz , D. Naber , M. Lambert
Nervenheilkunde 20 ( 6) 338 -351
2001
P.2.056 Antipsychotic polypharmacy in Germanyand Europe — results from a schizophrenia outpatient treatment observation study (SOHO)
M. Lambert , I. Czekalla , F. Langer , T. Wagner
European Neuropsychopharmacology 14
2004
P.2.055 Subjective well-being under neuroleptictreatment: Comparison of atypical versus typical antipsychotic 12-months monotherapy treatment in the SOHO Study
D. Naber , M. Lambert , F. Roesch , A. Ritzhaupt
European Neuropsychopharmacology 14
2004
Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function.
M. Zink , F. Schirmbeck , F. Rausch , S. Eifler
Acta Psychiatrica Scandinavica 130 ( 3) 214 -226
35
2014
Association of Positive and Negative Syndrome Scale short forms with global functioning and quality of life.
L. Hochstrasser , S. Borgwardt , M. Lambert , B. G. Schimmelmann
Acta Psychiatrica Scandinavica 134 ( 6) 563 -565
4
2016
Early detection and integrated care for adolescents and young adults with psychotic disorders: the ACCESS III study.
M. Lambert , D. Schöttle , F. Ruppelt , A. Rohenkohl
Acta Psychiatrica Scandinavica 136 ( 2) 188 -200
12
2017
Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
A. Karow , C. Brettschneider , H. Helmut König , C.U. Correll
Acta Psychiatrica Scandinavica 141 ( 3) 221 -230
2
2020
Cognitive and emotional empathy in individuals at clinical high risk of psychosis.
C. Montag , L. Brandt , A. Lehmann , W. De Millas
Acta Psychiatrica Scandinavica 142 ( 1) 40 -51
2
2020
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.
M. Lambert , P. Conus , D. I. Lubman , D. Wade
Acta Psychiatrica Scandinavica 112 ( 2) 141 -148
272
2005
Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophrenia
D. Naber , M. Riedel , A. Klimke , E.-U. Vorbach
Acta Psychiatrica Scandinavica 111 ( 2) 106 -115
82
2005
Subjective well-being under neuroleptic treatment and its relevance for compliance.
D. Naber , A. Karow , M. Lambert
Acta Psychiatrica Scandinavica 111 ( 427) 29 -34
90
2005